BridgeMD
New treatment option for Preeclampsia
Official title MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction
ClinicalTrials.gov ID: NCT07183384
What this study is testing
What is Mesenchymal Stem Cell-Derived Exosomes?
Mesenchymal Stem Cell-Derived Exosomes is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for preeclampsia.
Also referred to as MSC-Exos, Fetal stem cell exosomes.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- \--- Why Is This Study Being Done? Women who have preeclampsia during pregnancy face a much higher risk of heart disease later in life.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- Postpartum
- Confirmed diagnosis of preeclampsia in the last pregnancy
- Postpartum period of first week and second week
- Able to provide informed consent
You likely can't join if
- History of chronic hypertension prior to pregnancy
- Major cardiovascular disease history
- Active systemic infection
- Endothelial Injury history
- Active smoking status including vape, alcohol, drug addiction.
The study team makes the final eligibility decision.
Where it's taking place
- Bandung, West Java, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bandung, West Java, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.